The Uncomplicated Course of COVID-19 in Primary Immunodeficiency Patients: A Report of 14 Common Variable Immunodeficiency Patients

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NABAVI MOHAMMAD; MOHAMMADI FAEZEH; ARSHI SABA; BEMANIAN MOHAMMAD HASAN; FALLAHPOUR MORTEZA; Atashrazm Fatemeh; SHOKRI SIMA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY Year:2022 | Volume:21 | Issue:5 Page(s): 594-599

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

The Uncomplicated Course of COVID-19 in Primary Immunodeficiency Patients: A Report of 14 Common Variable Immunodeficiency Patients

Author(s)

Keywords

Common variable immunodeficiency

COVID-19

COVID-19 Vaccines

Primary immunodeficiency

Abstract

Coronavirus disease 2019 (COVID-19) affects millions of people worldwide. Clinical manifestations range from asymptomatic to severe viral pneumonia. CVID patients with COVID-19 infection are not adequately studied. In some studies, CVID patients had higher mortality rates, although other studies showed that CVID patients might have an uncomplicated COVID-19 infection. We describe 14 cases of COVID-19 infection in Iranian CVID patients in this study, including clinical manifestations, laboratory findings, and treatment strategies. There were 29% of patients with mild disease, 43% with moderate disease, and 29% with severe disease in this study. A critical case and a death occurred in none of our patients. There were six cases of infection more than two weeks after receiving the second dose of Sinopharm BIBP COVID-19 vaccine,all had mild to moderate disease. Among these patients, Remdesivir was the most frequently prescribed medication. According to this study, most of our patients presented with an uncomplicated disease course.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

NABAVI, MOHAMMAD, MOHAMMADI, FAEZEH, ARSHI, SABA, BEMANIAN, MOHAMMAD HASAN, FALLAHPOUR, MORTEZA, Atashrazm, Fatemeh, & SHOKRI, SIMA. (2022). The Uncomplicated Course of COVID-19 in Primary Immunodeficiency Patients: A Report of 14 Common Variable Immunodeficiency Patients. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 21(5), 594-599. SID. https://sid.ir/paper/1075507/en

Vancouver: Copy

NABAVI MOHAMMAD, MOHAMMADI FAEZEH, ARSHI SABA, BEMANIAN MOHAMMAD HASAN, FALLAHPOUR MORTEZA, Atashrazm Fatemeh, SHOKRI SIMA. The Uncomplicated Course of COVID-19 in Primary Immunodeficiency Patients: A Report of 14 Common Variable Immunodeficiency Patients. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2022;21(5):594-599. Available from: https://sid.ir/paper/1075507/en

IEEE: Copy

MOHAMMAD NABAVI, FAEZEH MOHAMMADI, SABA ARSHI, MOHAMMAD HASAN BEMANIAN, MORTEZA FALLAHPOUR, Fatemeh Atashrazm, and SIMA SHOKRI, “The Uncomplicated Course of COVID-19 in Primary Immunodeficiency Patients: A Report of 14 Common Variable Immunodeficiency Patients,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 21, no. 5, pp. 594–599, 2022, [Online]. Available: https://sid.ir/paper/1075507/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops